Dr Lal PathLabs IPO Details

Issue Open Dec 8, 2015
Issue Close Dec 10, 2015
IPO Price ₹550
Face Value ₹10
IPO Size ₹638.00 Cr
Listing At BSE, NSE
IPO Lot Size 20
  1. Mid Cap stocks that Big-3 MFs bought and sold in Mar-21

    Fri, 16 Apr 2021 00:30:00 GMT

    In India, the top 3 funds account for nearly 42% of the total AUM of the MF segment. Similarly, the top 10 AMCs account for 83% of the AUM of the mutual funds segment.

  2. Dr. Lal Pathlabs Ltd.

    Thu, 11 Mar 2021 16:00:00 GMT

    your Company completed its Initial Public Offering (IPO) of 1,16,00,000 equity shares of Rs. 10/– each, comprising of offer for sale of 12,61,996 equity shares by (Hony) Brig. Dr. Arvind Lal, 20 ...

  3. Aiming for both organic & inorganic growth: Dr Lal Pathlabs

    Tue, 22 Dec 2015 21:45:00 GMT

    A collection of the most-viewed Moneycontrol videos.

  4. Max Healthcare to float unit for diagnostics business foray

    Tue, 06 Apr 2021 07:33:00 GMT

    SRL was set to float an IPO at one point in time but nothing came of it. Meanwhile, peers Dr Lal PathLabs Ltd, Thyrocare Technologies Ltd and Metropolis have gone public in recent years on the back of ...

  5. The Covid billionaires: The 40 people who capitaliszed on Covid-19

    Wed, 07 Apr 2021 04:20:51 GMT

    Forbes' 2021 world's billionaires list includes 40 people who have been become billionaires due to their business efforts in fighting the global pandemic.

  6. Metropolis to focus on wellness, specialty tests & acquisitions to grow biz

    Sat, 27 Mar 2021 17:00:00 GMT

    Metropolis Healthcare, one of India’s largest diagnostic chain, which has announced an initial public offering (IPO) on March 28 ... Along with Metropolis, Lal Pathlabs, SRL, and Thyrocare ...

  7. Diagnostic chains see gradual increase in non-covid revenue

    Wed, 31 Mar 2021 22:24:00 GMT

    Metropolis Healthcare, Dr Lal Pathlabs, and SRL Diagnostics have shown an increase in revenue from their non-covid testing in successive quarters, and the companies are expecting this to increase ...

  8. Second Covid-19 Wave Likely To Hit Consumer Sentiment, Economic Recovery: Citi Research

    Mon, 12 Apr 2021 05:40:00 GMT

    Keenly awaiting FY22 revenue and margin guidance for HCL Technologies and Infosys. Expects Sun Pharma, Apollo Healthcare and Dr. Lal PathLabs to report strong numbers. For Cipla, strong U.S. numbers ...

  9. Beijing has more billionaires than any city in the world after bouncing back quickly from Covid-19, knocking New York off the top spot

    Thu, 08 Apr 2021 19:14:00 GMT

    Winner Medical's Initial public offering (IPO) on the Shenzhen stock market ... Executive chairman of Indian diagnostics chain Dr. Lal PathLabs - Medical Diagnostics 23. Prathap Reddy (India ...

  10. Dr. Lal Pathlabs Ltd - Stock Price

    Thu, 01 Apr 2021 05:19:00 GMT

    Dr. Lal Pathlabs Ltd. was incorporated in the year 1995. Its today's share price is 2708.1. Its current market capitalisation stands at Rs 22344.76 Cr. In the latest quarter, company has reported ...

Dr Lal PathLabs IPO Alerts

1. Listing of Dr. Lal PathLabs Limited IPO Shares  Wednesday, December 23, 2015 12:00:00 AM

The Equity Shares of Dr. Lal PathLabs Limited will list on the stock exchanges on Wednesday, December 23, 2015.

Detail of the Dr. Lal PathLabs IPO Share Listing is as below:

› Listing Date: Wednesday, December 23, 2015
› BSE Script Code: 539524
› NSE Symbol: LALPATHLAB
› Listing In: B Group of Securities
› ISIN: INE600L01024
› Issue Price: Rs. 550.00 Per Equity Share
› Face Value: Rs. 10.00 Per Equity Share

2. Dr. Lal PathLabs IPO allotment status  Saturday, December 19, 2015 12:00:00 AM

Dr. Lal PathLabs IPO allotment status is now available online.

Dr. Lal PathLabs IPO subscribed 33.41 times. Public Issue of Dr. Lal PathLabs was closed for subscription on Dec 10, 2015. Issue subscription detail:

Qualified Institutional Buyers (QIBs): 63.56 times
Non Institutional Investors (NII): 129.96 times
Retail Individual Investors (RIIs): 4.24 times

Dr. Lal PathLabs IPO Listing date will be available soon.

3. Dr. Lal PathLabs Limited IPO - Close  Thursday, December 10, 2015 12:00:00 AM

Dr. Lal PathLabs Limited IPO to open on Dec 8, 2015 and close for subscription on Dec 10, 2015. Company is raising Rs upto 638 Cr to achieve the benefits of listing the Equity Shares on the Stock Exchanges and for the Offer for Sale of up to 11,600,000 Equity Shares. The equity shares of the company to be list at BSE and NSE.

4. Dr. Lal PathLabs Limited IPO - Open  Tuesday, December 8, 2015 12:00:00 AM

Dr. Lal PathLabs Limited is entering in the capital markets with an initial public offering, IPO of 11,600,000 Equity Shares of Rs 10 each aggregating upto Rs 638 Cr. The price band for the issue has been fixed at Rs 540 at lower level and Rs 550 at upper level.

Dr. Lal PathLabs Limited is a Delhi based provider of diagnostic and related healthcare tests and services in India. Through its nationwide network, company offer patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.

The issue opens on Dec 8, 2015 and closes for subscription on Dec 10, 2015. The equity shares of the issue are proposed to be listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).

Dr Lal PathLabs IPO News & Events FAQs

  1. 1. When Dr Lal PathLabs IPO expected date?

    The Dr Lal PathLabs IPO is proposed to open on Dec 8, 2015. The IPO application ends on Dec 10, 2015.

  2. 2. How to purchase Dr Lal PathLabs IPO?

    Retail investors can apply in the retail or non-institutional investor category from Dec 8, 2015 to Dec 10, 2015. The Dr Lal PathLabs IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).

  3. 3. When Dr Lal PathLabs IPO will come?

    The Dr Lal PathLabs IPO will open for subscription on Dec 8, 2015. The public issue will close on Dec 10, 2015.


Comments

   I Like It. | Report Abuse








Search Chittorgarh.com:

Download Our Mobile App

Android App iOS App